PIERIS PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Pieris Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$4.18M, a 302% decline year-over-year.
  • Pieris Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$25.8M, a 30.6% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$29.8M, a 31.6% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$43.5M, a 16.1% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$51.8M, a 52.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$29.8M +$13.7M +31.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$43.5M +$8.36M +16.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$51.8M -$17.9M -52.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$33.9M -$6.76M -24.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 -$27.2M +$3.67M +11.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$30.8M -$16.2M -111% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$14.6M +$8.17M +35.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$22.8M -$9.08M -66.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 -$13.7M -$6.48M -90.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$7.2M -$7.75M -1400% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 $554K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.